Vaccinations in patients with multiple sclerosis: review and recommendations
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Vaccinations in patients with multiple sclerosis: review and recommendations
Authors
Keywords
-
Journal
MEDICAL JOURNAL OF AUSTRALIA
Volume 214, Issue 8, Pages 350
Publisher
AMPCo
Online
2021-04-19
DOI
10.5694/mja2.51012
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Risk of MS relapse after yellow fever vaccination
- (2020) Angela Huttner et al. Neurology-Neuroimmunology & Neuroinflammation
- Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis: The VELOCE study
- (2020) Amit Bar-Or et al. NEUROLOGY
- Practice guideline update summary: Vaccine-preventable infections and immunization in multiple sclerosis
- (2019) Mauricio F. Farez et al. NEUROLOGY
- Antibody response to seasonal influenza vaccination in patients with multiple sclerosis receiving immunomodulatory therapy
- (2018) H. K. Olberg et al. EUROPEAN JOURNAL OF NEUROLOGY
- Efficacy, effectiveness, and safety of herpes zoster vaccines in adults aged 50 and older: systematic review and network meta-analysis
- (2018) Andrea C Tricco et al. BMJ-British Medical Journal
- Varicella-zoster meningovasculitis in a multiple sclerosis patient treated with natalizumab
- (2017) Patricia Mulero et al. Multiple Sclerosis Journal
- Varicella-zoster meningovasculitis in a multiple sclerosis patient treated with natalizumab
- (2017) Patricia Mulero et al. Multiple Sclerosis Journal
- Vaccines and multiple sclerosis: a systematic review
- (2016) Mia Topsøe Mailand et al. JOURNAL OF NEUROLOGY
- Effect of teriflunomide on QuantiFERON-TB Gold results
- (2016) Alessandra Bua et al. MEDICAL MICROBIOLOGY AND IMMUNOLOGY
- Randomized trial of vaccination in fingolimod-treated patients with multiple sclerosis
- (2015) L. Kappos et al. NEUROLOGY
- Executive Summary: 2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
- (2014) Lorry G. Rubin et al. CLINICAL INFECTIOUS DISEASES
- Natalizumab treatment shows no clinically meaningful effects on immunization responses in patients with relapsing-remitting multiple sclerosis
- (2014) Michael Kaufman et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Varicella vaccination in the immunocompromised
- (2014) R. Malaiya et al. RHEUMATOLOGY
- Switching Therapies in Multiple Sclerosis
- (2013) Patricia K. Coyle CNS DRUGS
- Teriflunomide effect on immune response to influenza vaccine in patients with multiple sclerosis
- (2013) A. Bar-Or et al. NEUROLOGY
- Immune competence after alemtuzumab treatment of multiple sclerosis
- (2013) C. L. McCarthy et al. NEUROLOGY
- The Safety of Yellow Fever Vaccine 17D or 17DD in Children, Pregnant Women, HIV+ Individuals, and Older Persons: Systematic Review
- (2012) Roger E. Thomas et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Vaccination against infection in patients with multiple sclerosis
- (2012) Micha Loebermann et al. Nature Reviews Neurology
- Humoral immune response to influenza vaccine in natalizumab-treated MS patients
- (2012) Mattias Vågberg et al. NEUROLOGICAL RESEARCH
- Yellow Fever Vaccination and Increased Relapse Rate in Travelers With Multiple Sclerosis
- (2011) Mauricio F. Farez ARCHIVES OF NEUROLOGY
- A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis
- (2010) Gavin Giovannoni et al. NEW ENGLAND JOURNAL OF MEDICINE
- Use and Limitations of Varicella‐Zoster Virus–Specific Serological Testing to Evaluate Breakthrough Disease in Vaccinees and to Screen for Susceptibility to Varicella
- (2008) Judith Breuer et al. JOURNAL OF INFECTIOUS DISEASES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now